Microalbuminuria in heart transplant recipients -insights from the randomized trial dapagliflozin for renal protection in heart transplant recipients (DAPARHT)
29 August 2025 (07:00 - 18:00)
Organised by: 
About the speaker
Oslo University Hospital Rikshospitalet, Oslo (Norway)
6 More presentations in this session
Doctor M. Galvan Ruiz (Las Palmas de Gran Canaria, ES)
Miss M. Delgado Arija (Valencia, ES)
Associate Professor B. Sharif Kashani (Tehran, IR)
Causes and prognostic implications of hospital admissions following successful heart transplantation
Doctor M. Presume (Lisbon, PT)
Access the full session
The Event
ESC Congress 2025
29 August - 1 September 2025
You may be interested in
Congress Presentation
